SFM

Sphera Funds Management Portfolio holdings

AUM $382M
1-Year Return 0.41%
This Quarter Return
+20.31%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$754M
AUM Growth
+$149M
Cap. Flow
+$14.4M
Cap. Flow %
1.91%
Top 10 Hldgs %
48.98%
Holding
104
New
23
Increased
22
Reduced
27
Closed
20

Top Buys

1
SNY icon
Sanofi
SNY
$22.1M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$21.3M
3
NVS icon
Novartis
NVS
$18.9M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$11.4M
5
VTRS icon
Viatris
VTRS
$11.3M

Top Sells

1
ARQL
Arqule Inc
ARQL
$35.6M
2
CELG
Celgene Corp
CELG
$24.8M
3
SRPT icon
Sarepta Therapeutics
SRPT
$13.9M
4
GILD icon
Gilead Sciences
GILD
$13M
5
BMY icon
Bristol-Myers Squibb
BMY
$12.5M

Sector Composition

1 Healthcare 84.32%
2 Technology 10.06%
3 Industrials 1.58%
4 Consumer Discretionary 1.5%
5 Communication Services 0.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MLNX
76
DELISTED
Mellanox Technologies, Ltd.
MLNX
$990K 0.08%
8,452
-68,423
-89% -$8.01M
VIRX
77
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$723K 0.06%
61,194
– –
BLCM
78
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$516K 0.04%
40,000
-35,000
-47% -$452K
LRMR icon
79
Larimar Therapeutics
LRMR
$331M
$386K 0.03%
+28,973
New +$386K
IMVT icon
80
Immunovant
IMVT
$2.81B
$317K 0.03%
+20,000
New +$317K
CLRB icon
81
Cellectar Biosciences
CLRB
$15.9M
$197K 0.02%
292
– –
ABUS icon
82
Arbutus Biopharma
ABUS
$769M
– –
-500,000
Closed -$763K
AKRO icon
83
Akero Therapeutics
AKRO
$3.52B
– –
-130,000
Closed -$2.96M
CHTR icon
84
Charter Communications
CHTR
$35.4B
– –
-6,000
Closed -$2.47M
CUE icon
85
Cue Biopharma
CUE
$60.3M
– –
-50,000
Closed -$422K
DK icon
86
Delek US
DK
$1.92B
– –
-50,000
Closed -$1.82M
GILD icon
87
Gilead Sciences
GILD
$140B
– –
-205,000
Closed -$13M
IBB icon
88
iShares Biotechnology ETF
IBB
$5.68B
– –
0
– –
ITRN icon
89
Ituran Location and Control
ITRN
$674M
– –
-135,311
Closed -$3.35M
MRSN icon
90
Mersana Therapeutics
MRSN
$35.5M
– –
-8,000
Closed -$316K
NICE icon
91
Nice
NICE
$8.56B
– –
-57,193
Closed -$8.22M
STRO icon
92
Sutro Biopharma
STRO
$86.5M
– –
-422,589
Closed -$3.84M
URGN icon
93
UroGen Pharma
URGN
$870M
– –
-335,817
Closed -$8M
XBI icon
94
SPDR S&P Biotech ETF
XBI
$5.28B
– –
0
– –
TECX
95
Tectonic Therapeutic, Inc. Common Stock
TECX
$323M
– –
-10,527
Closed -$1.78M
PHXM
96
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
– –
-11,784
Closed -$523K
SGEN
97
DELISTED
Seagen Inc. Common Stock
SGEN
– –
0
– –
RETA
98
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-63,269
Closed -$5.08M
TUFN
99
DELISTED
Tufin Software Technologies Ltd.
TUFN
– –
-12,231
Closed -$201K
DRNA
100
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-565,000
Closed -$8.11M
1 2 3
4
5